Atrion: stocks, financial statements

Disable ads for free
Dividends News
Favorites

Development and production of products, primarily for medical use. It ranges from fluid delivery devices (such as valves) to eye and cardiovascular devices.The company also produces specialized medical devices for contact lens disinfection. It also produces measuring devices and related supplies that measure blood clotting time; and a line of products designed to safely hold a needle and scalpel blade.

In addition, there is a separate production of inflatable systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics. The company's clients are: doctors, hospitals, clinics and other medical centers; as well as other equipment manufacturers. Trade is carried out through direct sales, independent sales representatives and distributors.

  • ATRI Ticker
  • NASDAQ Exchange
  • 570 Employees
2 rated
  • $625.97, +$13.89 (+2.27%) Previous Close
  • 3,463 Previous Volume
  • $563.88 / $743.09 52 week low / high
  • -15.76% Percent off 52 week high
  • 2021-05-07 Updated
  • 1.09% Dividend Yield (trailing)
  • 1.12% Dividend Yield (forward)
  • 0 Public float
  • 1,827,841 Outstanding shares
  • 35.63 P/E
  • 1.14 B Market Cap
Disable ads for free

Financial statements — Atrion

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
150M 160M 150M 150M 140M
Cost Of Revenue
81M 84M 81M 76M 76M
Gross Profit
66M 71M 72M 71M 68M
Research and Development
5.6M 5M 5.5M 5.8M 6.6M
Selling General and Admin
25M 25M 25M 24M 22M
Operating Expense
110M 110M 110M 110M 100M
Operating Income
36M 41M 42M 41M 39M
Other Income Expense Net
0 0 0 0 0
EBIT
36M 41M 42M 41M 39M
Interest Income
0 0 0 0 -450K
Pretax Income
38M 43M 42M 42M 39M
Income Tax
6.4M 6.4M 7.8M 5.7M 12M
Minority Interest
0 0 0 0 0
Net Income
32M 37M 34M 37M 28M
Net Income Basic
32M 37M 34M 37M 28M
20 ← 16 2020 2019 2018 2017 2016
Current cash
42M 69M 68M 66M 44M
Short term investments
3.9M 2.5M 3.2M 3.2M 3.2M
Receivables
16M 19M 17M 17M 17M
Inventory
50M 42M 34M 29M 29M
Other current assets
3.9M 2.5M 3.2M 3.2M 3.2M
Current assets
110M 130M 120M 120M 94M
Long term investments
150M 130M 110M 89M 88M
Property plant equipment
95M 85M 75M 66M 65M
Goodwill
9.7M 9.7M 9.7M 9.7M 9.7M
Intangible assets
1.4M 1.5M 1.7M 1.8M 1.9M
Other assets
2.3M 2M 1.6M 1.5M 1.6M
Total assets
270M 260M 230M 200M 180M
Accounts payable
6.6M 5.7M 5.1M 3.9M 4M
Current long term debt
0 0 0 0 0
Other current liabilities
7M 5.6M 5.1M 5.7M 5M
Total current liabilities
14M 11M 10M 9.6M 9.1M
Long term debt
0 0 0 0 0
Other liabilities
2M 4.4M 3.5M 2.5M 1.1M
Minority Interest
0 0 0 0 0
Total Liabilities
26M 24M 20M 19M 20M
Common stock
1.8M 1.9M 1.9M 1.8M 1.8M
Retained earning
340M 320M 290M 270M 240M
Treasury stock
-150M -130M -130M -130M -110M
Capital surplus
Shareholder equity
240M 240M 210M 180M 160M
Net tangible assets
230M 230M 200M 170M 150M
20 ← 16 2020 2019 2018 2017 2016
Net Income
32M 37M 34M 37M 28M
Depreciation
12M 11M 9.1M 8.7M 9M
Changes in receivables
-2.4M 1.9M -62K -90K 550K
Changes in inventories
8.2M 8.5M 4.2M 340K -760K
Cash change
-27M 380K 2.8M 22M 16M
Cash flow
39M 42M 43M 47M 37M
Capital expenditures
-22M -20M -18M -9.7M -11M
Investments
Investing activity other
Total investing cash flows
-31M -45M -5.1M -21M -36M
Dividends paid
Net borrowings
-46M -71M -72M -69M -47M
Other financing cash flows
Cash flow financing
-31M -11M -9.5M -16M -9.5M
Exchange rate effect
Disable ads for free